Abstract

BackgroundThe use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes.Methods and FindingsA pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analysis. MGIT960 technique was compared with the Lowenstein-Jensen (LJ) method for laboratory diagnosis of active TB. Primary outcome was the proportion of patients who had their initial medical management changed within 2 months after randomisation. Secondary outcomes were: mean time for changing the procedure, patient satisfaction with the overall treatment and adverse events. Data were analysed by intention-to-treat. Between April 2008 and September 2011, 693 patients were enrolled (348 to MGIT, 345 to LJ). Smear and culture results were positive for 10% and 15.7% of participants, respectively. Patients in the MGIT arm had their initial medical management changed more frequently than those in the LJ group (10.1% MGIT vs 3.8% LJ, RR 2.67 95% CI 1.44–.96, p = 0.002, NNT 16, 95% CI 10–39). Mean time for changing the initial procedure was greater in LJ group at both sites: 20.0 and 29.6 days in MGIT group and 52.2 and 64.3 in LJ group (MD 33.5, 95% CI 30.6–36.4, p = 0.0001). No other important differences were observed.ConclusionsThis study suggests that opting for the MGIT960 system for TB diagnosis provides a promising case management model for improving the quality of care and control of TB.Trial RegistrationControlled-Trials.com ISRCTN79888843

Highlights

  • Tuberculosis (TB) is one of the world’s leading infectious diseases

  • This study suggests that opting for the MGIT960 system for TB diagnosis provides a promising case management model for improving the quality of care and control of TB

  • 893 people suspected of having TB were assessed for eligibility, and 693 were enrolled (348 to microscopy with a negative culture result (MGIT) and 345 to LJ)

Read more

Summary

Introduction

Tuberculosis (TB) is one of the world’s leading infectious diseases. In 2006, the World Health Organization’s Global Plan to Stop TB prioritized improving diagnosis and treatment to improve control of the disease [2]. In 2007, approximately 20–30% of the patients treated in low-income countries were treated for TB without bacteriological confirmation. Despite the fact that acid fast bacilli sputum smear microscopy has a low sensitivity (60%), it remains the most frequently used test for the diagnosis of pulmonary TB in low-income countries [3,4]. The acid fast bacilli smear sensitivity is even lower in (human immunodeficiency virus (HIV)—infected or immunosuppressed patients and in children (

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call